Metoclopramide Use in Children with GERD

Introduction to Metoclopramide Concerns

The American Academy of Pediatrics states that there is insufficient evidence to support the routine use of metoclopramide for the treatment of GERD in infants or older children, due to significant adverse effects 1, 2

Metoclopramide carries a black box warning from the FDA regarding serious adverse effects in the pediatric population, with adverse effects occurring in 11% to 34% of treated patients 1
Adverse effects of metoclopramide include drowsiness and restlessness 2 and irritability 2

A meta-analysis of 7 randomized controlled trials in patients younger than 2 years confirmed a decrease in GERD symptoms with metoclopramide, but this benefit came at the cost of significant adverse effects 1

Metoclopramide should only be considered in highly selected cases where conservative measures have failed, there is documented pathologic reflux on pH monitoring, and the child has severe, refractory symptoms with clear GERD features 1, 3

First-line management should focus on conservative measures, including smaller, more frequent feedings, thickened feedings, upright positioning when awake and supervised, and maternal elimination diet if breastfeeding 3, 4
If pharmacologic therapy is needed, H2 receptor antagonists are preferred as first-line for confirmed pathologic reflux, and PPIs are appropriate only if erosive esophagitis is confirmed on endoscopy 3

Clinical features that suggest true GERD include recurrent regurgitation with failure to thrive, dystonic neck posturing in infants, and heartburn/epigastric pain in older children 2, 5
If diagnosis is uncertain, upper endoscopy with biopsy is the primary diagnostic method, and 24-hour pH monitoring can quantify reflux and detect pathologic reflux 3, 5

Avoid the temptation to use metoclopramide for symptom control in irritable infants without confirmed GERD, as the risks outweigh benefits 1, 2

Most infant reflux is physiologic and self-limited, not requiring medication, and the supine sleep position does not increase choking risk in infants with gastroesophageal reflux because infants have protective airway mechanisms, according to the American Academy of Pediatrics 6, 7
Infants should continue sleeping on their back (supine position) for every sleep to reduce SIDS risk, even with reflux symptoms, as recommended by the American Academy of Pediatrics 6, 7
Keeping the infant completely upright after feeds when awake and observed is a recommended conservative management strategy 8
The American Academy of Pediatrics recommends against elevating the head of the crib, as it is ineffective for reducing reflux and may cause the infant to slide into a position that compromises respiration 6, 7
The American Academy of Pediatrics also recommends never placing the infant prone (on stomach) for sleep, even with reflux, as the SIDS risk outweighs any reflux benefit 6, 7